Archived Bulletins

April 23, 2018

Published: April 23, 2018
Category: Trials

NEC 2 ( NCT01229943) Randomized Phase II Study of Everolimus Alone versus Everolimus Plus Bevacizumab in Patients with Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumours has been permanently closed by the lead group.

About the trial

Read More

Published: April 23, 2018
Category: Group updates
This Friday is the CCTG 2018 Annual Spring Meeting of Participants

This Friday is the CCTG 2018 Annual Spring Meeting of Participants

The Canadian Cancer Trials Group Annual Spring Meeting of Participants represents a major gathering of the Canadian oncology community where trials that cover the spectrum of cancer treatment are designed and reviewed. Traditionally, the meeting includes discussions of trials that are in development, under conduct or have results to be shared.

Online registration has closed and on site registration will open Friday April 27 at the Chelsea Hotel.

Read More

Published: April 23, 2018
Category: Group updates

The Central Operations and Statistics Office located at Queen's University in Kingston, Ontario has a job opening for a Safety Desk Team Leader

Read More

Published: April 23, 2018
Category: News

  Ovarian Cancer Canada | Cancer de l'ovaire Canada

Ovarian Cancer Canada asks us to urge the government to fund ovarian cancer research in Canada

Read More

April 11, 2018

Published: April 11, 2018
Category:

CCTG is pleased to announce that the OV.25 trial, A Randomized Phase II Double-Blind Placebo-Controlled Trial of Acetylsalicylic Acid (ASA) in Prevention of Ovarian Cancer in Women with BRCA 1/2 Mutations (STICs and STONEs) has been centrally activated.

Read More

Published: April 11, 2018
Category: Trials
trials which have now been deemed permanently closed/terminated by their respective lead group

There are three intergroup-led trials which have now been deemed permanently closed/terminated by their respective lead group. If you have any questions regarding the trial closure please contact:Christine Bertrim.

Data submission and REB approval for the following trials is no longer required:

Read More

Published: April 11, 2018
Category: Group updates

The official CCTG Facebook page is here!

With so many of our partners and collaborators already using this social media platform, CCTG has officially joined the Cancer Clinical Trials conversation on Facebook. The group's new social media page will focus on sharing lay related stories and information on the subject of cancer clinical trials. With emerging treatments and clinical practice changes it is a great way to keep everyone up-to-date with the latest information in the ever changing world of cancer research.

Read More

Published: April 11, 2018
Category: Group updates
Janet Dancy and Julie Wells - last year's awards

Each year, at the CCTG Annual Spring Meeting of Participants, we recognize individuals and groups who have made significant contributions to cancer clinical trials research. Winners will be honoured on the evening of Friday, April 27 at the CCTG Recognition Awards Ceremony in Toronto.

Read More